Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...

Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...

A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...

Astellas’ menopause treatment has been accepted for FDA review, five months after the therapy hit a speed bump in a phase 3 trial conducted in Asia.

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.

A decades-old label has scared women (and their doctors) away from safe and effective menopause treatment. That could finally change today.

The US Food and Drug Administration on Friday approved a new type of drug to treat hot flashes and night sweats during menopause. Veozah, or fezolinetant, made by Astellas Pharma, is the first ...

While lifestyle approaches like diet and exercise may help with some menopause discomfort, for severe symptoms of hot flashes, mood changes, or vaginal dryness, hormone replacement therapy (HRT ...

The FDA approved TherapeuticsMD’s hormone therapy Imvexxy for a vaginal condition linked to low estrogen levels during menopause, the company announced May 30. 1. Imvexxy is intended to treat ...

Bioidentical or plant-derived hormones have uncertain efficacy or safety in treating menopausal symptoms. What is the evidence supporting the use of compounded and FDA-approved bioidentical products?

The evidence review uncovered 10 studies looking at the impact of cognitive behavioral therapy on menopause symptoms, and nine evaluating the helpfulness of mindfulness meditation.

In this review, the rationale behind the use of bioidentical hormones is discussed, along with the evidence supporting the use of compounded and FDA-approved bioidentical products. Vasomotor symptoms ...